S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
Log in

Array Biopharma SEC Filings & 10K Form (NASDAQ:ARRY)

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range N/A
50-Day Range
$47.85
MA: $47.85▼
$47.85
52-Week Range N/A
Volume206,500 shs
Average Volume4.99 million shs
Market Capitalization$10.68 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.7

SEC Filings

Array Biopharma (NASDAQ:ARRY) SEC Filings

DateFilerForm TypeView
08/12/2019
9:20 AM		Array Biopharma (Subject)
FMR LLC (Filed by)
Form SC 13G/A
08/09/2019
7:30 AM		Array Biopharma (Filer)
Form 15-12B
07/31/2019
11:15 PM		Array Biopharma (Filer)
Form EFFECT
07/31/2019
11:15 PM		Array Biopharma (Filer)
Form EFFECT
07/31/2019
11:15 PM		Array Biopharma (Filer)
Form EFFECT
07/31/2019
11:15 PM		Array Biopharma (Filer)
Form EFFECT
07/31/2019
11:15 PM		Array Biopharma (Filer)
Form EFFECT
07/31/2019
11:15 PM		Array Biopharma (Filer)
Form EFFECT
07/31/2019
11:15 PM		Array Biopharma (Filer)
Form EFFECT
07/31/2019
11:15 PM		Array Biopharma (Filer)
Form EFFECT
07/31/2019
11:15 PM		Array Biopharma (Filer)
Form EFFECT
07/31/2019
11:15 PM		Array Biopharma (Filer)
Form EFFECT
07/31/2019
11:15 PM		Array Biopharma (Filer)
Form EFFECT
07/31/2019
11:15 PM		Array Biopharma (Filer)
Form EFFECT
07/30/2019
7:06 PM		Array Biopharma (Issuer)
VAN LUNSEN GIL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2019
7:06 PM		Array Biopharma (Issuer)
Squarer Ron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2019
7:05 PM		Array Biopharma (Issuer)
Sharp Shalini (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2019
7:05 PM		Array Biopharma (Issuer)
Sandor Victor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2019
7:04 PM		Array Biopharma (Issuer)
Saccomano Nicholas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2019
7:04 PM		Array Biopharma (Issuer)
Robbins Andrew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2019
7:04 PM		Array Biopharma (Issuer)
Orwin John A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2019
7:03 PM		Array Biopharma (Issuer)
LEFKOFF KYLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2019
7:03 PM		Array Biopharma (Issuer)
Haddock Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2019
7:03 PM		Array Biopharma (Issuer)
Fyfe Gwen A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2019
7:02 PM		Array Biopharma (Issuer)
COX CARRIE SMITH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2019
7:02 PM		Array Biopharma (Issuer)
BAUM CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2019
8:28 AM		Array Biopharma (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
07/30/2019
8:11 AM		Array Biopharma (Filer)
Form S-8 POS
07/30/2019
8:11 AM		Array Biopharma (Filer)
Form S-8 POS
07/30/2019
8:09 AM		Array Biopharma (Filer)
Form S-8 POS
07/30/2019
8:08 AM		Array Biopharma (Filer)
Form S-8 POS
07/30/2019
8:07 AM		Array Biopharma (Filer)
Form S-8 POS
07/30/2019
8:06 AM		Array Biopharma (Filer)
Form S-8 POS
07/30/2019
8:05 AM		Array Biopharma (Filer)
Form S-8 POS
07/30/2019
8:04 AM		Array Biopharma (Filer)
Form S-8 POS
07/30/2019
8:03 AM		Array Biopharma (Filer)
Form S-8 POS
07/30/2019
8:01 AM		Array Biopharma (Filer)
Form S-8 POS
07/30/2019
8:00 AM		Array Biopharma (Filer)
Form S-8 POS
07/30/2019
7:56 AM		Array Biopharma (Filer)
Form POS AM
07/30/2019
7:55 AM		Array Biopharma (Filer)
Form POS AM
07/30/2019
7:54 AM		Array Biopharma (Filer)
Form POS AM
07/30/2019
7:53 AM		Array Biopharma (Filer)
Form POS AM
07/30/2019
7:52 AM		Array Biopharma (Filer)
Form POS AM
07/30/2019
7:51 AM		Array Biopharma (Filer)
Form POS AM
07/30/2019
7:51 AM		Array Biopharma (Filer)
Form POS AM
07/30/2019
7:50 AM		Array Biopharma (Filer)
Form POS AM
07/30/2019
7:49 AM		Array Biopharma (Filer)
Form POS AM
07/30/2019
7:47 AM		Array Biopharma (Filer)
Form POS AM
07/30/2019
7:46 AM		Array Biopharma (Filer)
Form POS AM
07/30/2019
7:45 AM		Array Biopharma (Filer)
Form POS AM
07/30/2019
7:43 AM		Array Biopharma (Filer)
Form POSASR
07/30/2019
7:39 AM		Array Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2019
7:37 AM		Array Biopharma (Subject)
Form SC 14D9/A
07/30/2019
7:35 AM		Array Biopharma (Subject)
PFIZER INC (Filed by)
Form SC TO-T/A
07/29/2019
7:33 AM		Array Biopharma (Subject)
Form SC 14D9/A
07/29/2019
7:32 AM		Array Biopharma (Subject)
PFIZER INC (Filed by)
Form SC TO-T/A
07/25/2019
4:17 PM		Array Biopharma (Subject)
Form SC 14D9/A
07/25/2019
4:17 PM		Array Biopharma (Subject)
PFIZER INC (Filed by)
Form SC TO-T/A
07/17/2019
4:19 PM		Array Biopharma (Subject)
PFIZER INC (Filed by)
Form SC TO-T/A
07/17/2019
4:10 PM		Array Biopharma (Subject)
Form SC 14D9/A
07/12/2019
4:16 PM		Array Biopharma (Subject)
PFIZER INC (Filed by)
Form SC TO-T/A
07/12/2019
4:11 PM		Array Biopharma (Subject)
Form SC 14D9/A
07/11/2019
4:24 PM		Array Biopharma (Subject)
PFIZER INC (Filed by)
Form SC TO-T/A
07/11/2019
4:16 PM		Array Biopharma (Subject)
Form SC 14D9/A
07/10/2019
1:58 PM		Array Biopharma (Subject)
FMR LLC (Filed by)
Form SC 13G/A
07/08/2019
4:18 PM		Array Biopharma (Subject)
PFIZER INC (Filed by)
Form SC TO-T/A
07/08/2019
4:14 PM		Array Biopharma (Subject)
Form SC 14D9/A
07/03/2019
2:47 PM		Array Biopharma (Subject)
PFIZER INC (Filed by)
Form SC TO-T/A
07/03/2019
2:42 PM		Array Biopharma (Subject)
Form SC 14D9/A
06/28/2019
12:48 PM		Array Biopharma (Subject)
Form SC 14D9
06/28/2019
12:36 PM		Array Biopharma (Subject)
PFIZER INC (Filed by)
Form SC TO-T
06/18/2019
4:01 PM		Array Biopharma (Subject)
PFIZER INC (Filed by)
Form SC TO-C
06/17/2019
4:16 PM		Array Biopharma (Subject)
PFIZER INC (Filed by)
Form SC TO-C
06/17/2019
7:39 AM		Array Biopharma (Subject)
Form SC14D9C
06/17/2019
7:36 AM		Array Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2019
7:34 AM		Array Biopharma (Subject)
Form SC TO-C
06/17/2019
6:10 AM		Array Biopharma (Subject)
PFIZER INC (Filed by)
Form SC TO-C
06/06/2019
3:02 PM		Array Biopharma (Issuer)
Sandor Victor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
3:03 PM		Array Biopharma (Issuer)
Sandor Victor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
3:04 PM		Array Biopharma (Issuer)
Sandor Victor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
4:26 PM		Array Biopharma (Issuer)
Sandor Victor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2019
7:02 AM		Array Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2019
8:08 AM		Array Biopharma (Filer)
Form 424B5
05/07/2019
7:14 AM		Array Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2019
7:12 AM		Array Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2019
3:31 PM		Array Biopharma (Issuer)
Robbins Andrew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
3:31 PM		Array Biopharma (Issuer)
Squarer Ron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
3:30 PM		Array Biopharma (Issuer)
Saccomano Nicholas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
3:30 PM		Array Biopharma (Issuer)
Sandor Victor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
3:54 PM		Array Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2019
2:40 PM		Array Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2019
3:30 PM		Array Biopharma (Issuer)
COX CARRIE SMITH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2019
3:26 PM		Array Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2019
8:41 AM		Array Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/08/2019
6:14 PM		Array Biopharma (Issuer)
LEFKOFF KYLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
5:36 PM		Array Biopharma (Issuer)
Robbins Andrew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
5:34 PM		Array Biopharma (Issuer)
Haddock Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
5:32 PM		Array Biopharma (Issuer)
Saccomano Nicholas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
5:31 PM		Array Biopharma (Issuer)
Squarer Ron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2019
3:30 PM		Array Biopharma (Issuer)
Oltmans Curtis Gale (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 11/13/2019 by MarketBeat.com Staff

Featured Article: What does earnings per share mean?
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel